Pharmacologically active microcarriers releasing glial cell line - derived neurotrophic factor: Survival and differentiation of embryonic dopaminergic neurons after grafting in hemiparkinsonian rats.

Abstract

To improve the outcome of foetal dopaminergic cell transplantation for the treatment of Parkinson's disease, pharmacologically active microcarriers (PAM) were developed. PAM are able to convey cells on their surface and release a growth factor to improve cell survival, differentiation and integration after brain implantation. Lysozyme-releasing PAM were… (More)

Topics

Cite this paper

@article{Tatard2007PharmacologicallyAM, title={Pharmacologically active microcarriers releasing glial cell line - derived neurotrophic factor: Survival and differentiation of embryonic dopaminergic neurons after grafting in hemiparkinsonian rats.}, author={Val{\'e}rie M Tatard and Laurence Sindji and Jennifer Godbee Branton and Anne Aubert-Pou{\"e}ssel and Jacqueline Colleau and Jean-Pierre Beno{\^i}t and Claudia N. Montero-Menei}, journal={Biomaterials}, year={2007}, volume={28 11}, pages={1978-88} }